Vascular Solutions (VASC) reported quarterly earnings results on Monday, Apr-25-2016. The company said it had a profit of $0.25 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.02. Analysts had a consensus of $0.23. The company posted revenue of $39.40 million in the period, compared to analysts expectations of $38.37 million. The company’s revenue was up 13.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.21 EPS.
Vascular Solutions closed down -0.82 points or -2.14% at $37.5 with 1,17,662 shares getting traded on Friday. Post opening the session at $38.2, the shares hit an intraday low of $37.3 and an intraday high of $38.35 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on Nov 20, 2015, Jorge Saucedo (director) sold 7,715 shares at $33.45 per share price. According to the SEC, on Nov 6, 2015, Richard Nigon (director) sold 8,000 shares at $32.40 per share price. On Nov 3, 2015, Howard Root (Chief Executive Officer) sold 18,062 shares at $32.03 per share price, according to the Form-4 filing with the securities and exchange commission.
Vascular Solutions Inc. is a medical device company which creates minimally invasive medical devices and then delivers these products and services to physicians through its direct domestic sales force and its international distribution network. It offers products and services in three categories: Catheter products which consist of catheters used in minimally invasive medical procedures for the treatment of vascular conditions such as GuideLiner and Pronto extraction catheters and includes micro-introducer kits for gaining percutaneous access to the vasculature; Hemostat products which consist of the D-Stat Dry hemostat to control surface bleeding D-Stat Flowable for preventing bleeding in subcutaneous pockets Accumed wrist positioning splints and Vasc Band inflatable compression bands and Vein products which consist of the Vari-Lase endovenous laser for the treatment of varicose veins and a reprocessing service for the ClosureFAST radiofrequency vein ablation catheter.